A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

Condition:   Benign Prostatic HyperplasiaInterventions:   Drug: MK0906, finasteride / Duration of Treatment: 48 weeks;   Drug: Comparator: placebo / Duration of Treatment: 48 weeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials